Samuel F. Straface

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.

SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston.

Part of Johnson & Johnson, Sensera, Inc. is a company that manufactures sensors and modules. The company is based in Woburn, MA. The company was founded by Marc-Andre Lebel. Sensera was acquired by ABIOMED, Inc., a subsidiary of Johnson & Johnson from Sensera Ltd. on January 04, 2022 for $7.50 million.

Pittsburgh Life Sciences Green House (PLSG) is a venture capital firm founded in 2002. The firm is headquartered in Pittsburgh, Pennsylvania.

Founded in 2002, PLSG Capital Investment Programs is a venture capital/private equity firm located in Pittsburgh, Pennsylvania.

Medrobotics Corp. operates as a surgical products company which develops flexible robot platforms. It manufactures and markets product, Flex System, a computer-assisted platform that provides surgeons with single-site access and visualization of hard-to-reach anatomical locations. The firm's Flex System is based on a core flexible endoscope technology that surgeons can use with an integrated high-definition vision system to navigate around anatomy in a way that is not possible with line-of-sight approaches. The company was founded by Howie Choset, Marco A. Zenati and Alon Wolf in 2005 and is headquartered in Raynham, MA.